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Introduction: Familial adenomatous polyposis (FAP), an autosomal dominant disease char-
acterized by development of numerous adenomatous polyps in the colon and rectum, is
caused by germline mutations in the Adenomatous Polyposis Coli (APC) gene.
Methods: To determine the surgical morbidity in patients with classical familial adeno-
matous polyposis and determine the incidence of metachronous colorectal cancer (CRC) in
those undergoing total colectomy (TC) with ileorectal anastomosis or restorative total proc-
tocolectomy (TPC) and ileal pouch anal anastomosis. We  analyzed patients with familial
adenomatous polyposis who received treatment and regular follow-up at the A.C. Camargo
Cancer Center from 1994 to 2013.
Results: Operative complications occurred in 22 patients (34.3%), 16 (25%) being early compli-
cations and 8 (12.5%) late complications. No mortality occurred as a result of postoperative
complications. The incidence of metachronous rectal cancer after total proctocolectomy
was 2.3% and after total colectomy 18.18% (p = 0.044).
Conclusions: In order to provide better quality of life for individuals with familial ade-
nomatous polyposis, total colectomy is commonly offered, as this simple technique is
traditionally associated with lower rates of postoperative complications and better func-
tional outcomes. However, it has become a less attractive technique in patients with familial
adenomatous polyposis in its classical or diffuse form, since it has a signiﬁcantly higher
probability of metachronous rectal cancer.© 2015 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. All
rights reserved.
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Complicac¸ões cirúrgicas  e  risco  de  câncer  retal  metacrônico  em  pacientes
com  polipose  adenomatosa  familiar  clássica
Palavras chave:
Polipose adenomatosa familiar
Câncer colorretal
Colectomia total
Pólipos adenomatosos
Proctocolectomia restaurativa
r  e  s  u  m  o
Introduc¸ão: Polipose adenomatosa familiar (PAF), uma doenc¸a autossômica dominante car-
acterizada pela formac¸ão de numerosos pólipos adenomatosos no cólon e reto, é causada
por  mutac¸ões da linha germinativa no gene da polipose adenomatosa do cólon (PAC).
Métodos: Para determinar a morbidade cirúrgica em pacientes com PAF clássica e determi-
nar  a incidência de câncer colorretal (CCR) metacrônico naqueles pacientes submetidos à
colectomia total (CT) com anastomose íleo-retal ou submetidos à proctocolectomia restau-
rativa (PCT) e anastomose bolsa ileal-anal, foram analisados pacientes com PAF que foram
tratados e tiveram acompanhamento periódico no A. C. Camargo Cancer Center de 1994 até
2013.
Resultados: Ocorreram complicac¸ões cirúrgicas em 22 pacientes (34,3%); 16 (25%) tiveram
complicac¸ões precoces e 8 (12,5%) complicac¸ões tardias. Não houve mortes como resultado
de  complicac¸ões pós-operatórias. A incidência de câncer de reto metacrônico após PCT foi
de  2,3% e após CT foi de 18,18% (p = 0,044).
Conclusões: A ﬁm de proporcionar melhor qualidade de vida para os pacientes com PAF,
CT  é comumente oferecida, pois esta técnica simples está tradicionalmente associada com
menores percentuais de complicac¸ões pós-operatórias e melhores resultados funcionais.
No entanto, CT se tornou uma técnica menos atraente em pacientes com PAF em sua forma
clássica ou difusa, uma vez que traz consigo uma probabilidade signiﬁcativamente maior
de  câncer retal metacrônico.
© 2015 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda.
Todos os direitos reservados.
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gical procedure was performed. The aim being to ascertainntroduction
amilial adenomatous polyposis (FAP), an autosomal domi-
ant disease characterized by the development of hundreds to
housands of adenomatous polyps in the colon and rectum, is
aused by germline mutations in the Adenomatous Polyposis Coli
APC) gene, which is in chromosomal region 5q21-22.1,2 This
utation is present in 1 in 10,000 live births, and accounts for
% of the cases of colorectal cancer (CRC).3
In classical polyposis polyps, mainly in the distal colon (rec-
osigmoid), often develop during childhood and increase in
ize and number in adolescence, when they characteristically
evelop throughout the colon. Half of these patients develop
denomas by the age of 15 years and 95% by the age of 35.1
enomic penetrance is approximately 100%. The median age
f diagnosis of CRC is 39 years; however, 7% of patients develop
RC before the age of 21.
Essential steps in the management of patients with FAP
nclude early diagnosis of affected individuals, performance
f prophylactic colectomy when appropriate, genetic coun-
eling, recognition of various extracolonic manifestations and
dequate postoperative follow-up.1
Surgery is the most effective means of preventing CRC,
ainly in the form of total colectomy with ileorectal anas-
omosis (IRA) or total proctocolectomy (TPC) followed by ileal
ouch and ileoanal anastomosis.4 Preservation of the rectum
s associated with better functional outcomes and less mor-
idity, but carries a risk of metachronous tumor in the stump
emnant.5,6 Decisions concerning the best procedure for each
atient should be based on factors such as age, location andnumber of polyps, location of genetic mutation and patient
acceptance of undergoing regular postoperative follow-up.
Until 1980, prophylactic restorative proctocolectomy and
ileal pouch anal anastomosis was the procedure of choice for
the treatment of FAP. Thereafter, TPC followed by ileal pouch
and ileoanal anastomosis became the gold standard for treat-
ment of the classic or diffuse form of this disease.3
Our objectives were to assess surgical morbidity in patients
with classical FAP and ascertain the risk of metachronous CRC
in the anorectal region in patients who had undergone TC with
IRA or TPC with ileal pouch, these being the most commonly
performed procedures in most institutions.
Patients  and  methods
Relevant data of patients with FAP who were added to the
hereditary CRC registry of the A.C. Camargo Cancer Center
(HACC) from 1994 to 2013 were retrospectively analyzed. The
diagnoses of FAP had been established by clinical history
and colonoscopy with histological analysis of some resected
polyps.
The study analyzed 86 patients (from 34 families) with FAP
who had received genetic counseling and regular follow-up
treatment. Eighty-two of these patients underwent surgical
treatment. Studied variables were epidemiological and sur-the incidence of metachronous rectal cancer after TC or TPC,
ten patients who had undergone noncurative surgical treat-
ments or procedures other than TC and TPC were excluded,
10  j coloproctol (rio j). 2
34 FAP families
(620 individuals in 4 generations)
104 individuals
with colorectal cancer
67 deaths from colorectal cancer
• 02 lost to follow
• 06 patients with attenuated FA P
• 04 others who were not operated
• 10 patients underwent another surgical method or purpose
64 with classic FA P analyzed
 – 42 restorative proctocolectomy  and ileal pouch anal anastomosis (TPC)
 – 22 total colectomy  with ileorectal anastomosis (TC)
183 patients with FAP
86 patients - Follow  in HACCFig. 1 – Selection of patients for the study.
as were six with attenuated FAP and four others who refused
to undergo preventive surgical treatment. Of the remaining 64
patients, 42 underwent TPC and 22 TC (Fig. 1).
For TC, approximately 15 cm of rectum was preserved, fol-
lowed by performing primary IRA end-to-end with a 29 mm
circular stapler. TPC consisted of resection of the colon and
rectum, followed by reconstruction of a means of intestinal
transit with a mechanical bowel anastomosis by a double sta-
pling technique involving fashioning an 15 cm ileal J-pouch
using two staplings of 75 mm and anastomosing this pouch to
the anal canal with a 29 mm circular stapler. In these, pro-
tective ileostomy was performed and also routine drainage
(Fig. 2).
Fig. 2 – Ileal J-pouch with 15 cm extension, fashioned with
mechanical sutures and placement of the pointed arch of
the stapler for ileoanal anastomosis (pouch–anus) by a
double stapling technique. Restorative proctocolectomy and
ileal pouch anal anastomosis in patients with Familial
adenomatous polyposis are shown. 0 1 5;3 5(1):8–13
The follow-up routine of patients with colorectal tumors
treated at the institution included a clinical visit every
three months during the ﬁrst two years that included lab-
oratory tests, tumor marker evaluation, chest X-ray and
abdominal ultrasound or cross-sectional imaging (tomogra-
phy), alternately. From the third to the ﬁfth year, this
routine examination was performed every six months,
after which it was conducted annually. Proctosigmoidoscopy
was repeated annually in FAP patients who  underwent
surgery. When recurrence was detected, tests were requested
for re-staging and therapeutic planning purposes. Positron
emission tomography–computed tomography (PET–CT) was
requested in cases where the risk of metastases was deemed
higher.
Correlation coefﬁcients between all ﬁndings were esti-
mated using Pearson correlation. Either the 2 test or Fisher’s
exact test (two sided) was performed to determine the
correlation between all groups. Results were considered sta-
tistically signiﬁcant at p < 0.05. All statistical analyses were
conducted using the SPSS 20.0 statistical software program
(SPSS, Chicago, IL).
Results
During the study period, 34 families consisting of 620 individ-
uals over four generations were identiﬁed as having FAP. Of
these, 183 subjects (29.5%) were identiﬁed as having intestinal
polyps, 104 (56.8%) had CRC and of these, 67 (64.42%) pro-
gressed to death (Fig. 1). The median age of diagnosis of CRC
was 36 years and the prevalence of CRC did not differ signiﬁ-
cantly according to sex (30.6% and 26.2% in male and female
subjects, respectively; p = 0.64).
The targets of this study, 64 family members of patients
with classic FAP (>100 polyps), were followed up regularly at
our institution. The mean duration of follow-up was 13-231
months (median 90 months). The median age of diagnosis
of FAP was 30 (13–45) years. Of these individuals, 42 under-
went TPC and 22 TC. Table 1 shows the incidence of early and
late postoperative complications for each procedure. Opera-
tive complications occurred in 22 patients (34.3%), 16 (25%)
being early complications (up till the 30th postoperative day)
and 8 (12.5%) late complications. No mortality occurred as a
result of postoperative complications.
Overall, signiﬁcantly more  complications occurred in the
TPC (42.8%) than in the TC group (18.18%) (p = 0.048).
Anastomotic leakage was the commonest early complica-
tion and subocclusion or bowel obstruction the commonest
late complication. Most patients who developed anastomotic
leakage (six TPC and two TC) were treated conservatively:
in only one case was a new surgical intervention, fashion-
ing of a permanent ileostomy, necessary. Among patients
who developed obstruction, ﬁve underwent laparotomy with
lysis of adhesions and/or enterectomy. One patient developed
necrosis of the ileal reservoir and subsequently under-
went a further surgical intervention to fashion a permanent
stoma.
The incidence of metachronous rectal cancer after TPC was
2.3% and after TC 18.18% (in the rectal remnant; p = 0.025;
Fig. 3).
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Table 1 – Early and late postoperative surgical complications.
Restorative proctocolectomy
and ileal pouch anal
anastomosis (TPC 42)
Total colectomy
(TC 22)
Total  (%)
Early complications
Postoperative infections/leakage 3 1 4
Anastomotic leakage 6 2 8
Bowel obstruction 1 1 2
Bleeding 1 – 1
Pouch necrosis 1 – 1
Subtotal (n complications) 12 (28.57%) 4 (18.18%) 16 (25%)
Late complications
Subocclusion/bowel obstruction 4 1 5
Urinary incontinence 1 - 1
Stenosis anastomosis 1 - 1
Electrolyte imbalance 1 - 1
Subtotal (n complications) 7  (16.6%) 1 (4.5%) 8 (12.5%)
Total cases/complications (% individuals) 18/19 (42.8%) 4/5 (18.18%) 22/24 (34.3%)
Table 2 – Characteristics of patients with metachronous rectal lesions according to type of surgery and requirement for
surgical salvage.
Surgery type Age Disease free
survival
Staging Treatment recurrence
Proctocolectomy and ileal pouch anal anastomosis 51 years 10 years T1N0M0 Local resection
Total colectomy with ileorectal anastomosis 46 years 3 years T1N0M0 Complete proctectomy and ileal
pouch anal anastomosis
Total colectomy with ileorectal anastomosis 55 years 5 months T1N0M0 Complete proctectomy and ileal
pouch anal anastomosis
Total colectomy with ileorectal anastomosis 50 years 7 years T2N0M0 Abdominoperineal amputation
Total colectomy with ileorectal anastomosis 33 years 
97,6% (n=41)
81,81%(n=18)
2,3% (n=01)
18,18%(n=04)
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without metachronous rectal cancer
with metachronous rectal cancer
Fig. 3 – Metachronous rectal cancer in patients with FAP
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patient, thus requiring longer periodic rectal monitoring.ccording to type of surgery. X2 test (n = 64); p = 0.044.
Most of the metachronous rectal cancers that developed
fter TC (n = 22) did so within the ﬁrst 10 years of follow-up
n = 4). All the patients who had undergone TC and not devel-
ped neoplastic lesions (n = 18) had been followed up for more
han 5 years. The only metachronous CRC that developed after
PC was diagnosed after 10 years of follow-up; local resection
as performed. Some patients who had undergone TC with
reservation of the rectum subsequently were required to
ave residual rectal resection or abdominoperineal amputa-
ion because of invasive adenocarcinoma near the dentate line
nd/or uncontrollable numbers of polyps (Table 2).2 years T1N0M0 Complete proctectomy and ileal
pouch anal anastomosis
Discussion
Compared with TPC, the procedure of TC with ileorectal anas-
tomosis has less morbidity, preserves the rectum, provides
continence, does not require extensive pelvic dissection and
allows for immediate reconstruction of the bowel, without
the need for a temporary stoma. However, depending on the
duration of monitoring and age of the patient, the incidence
of metachronous cancer in the rectal remnant is reportedly
7–37%,7–11 which is a major drawback compared with TPC.
Thus, our preferred treatment for patients with classical FAP
and more  than 20 polyps in the rectum is TPC followed by
ileal pouch ileoanal anastomosis. We  reserve TC with ileorec-
tal anastomosis for individuals with attenuated FAP and few
rectal polyps and for those in whom it is difﬁcult to fashion
an ileal pouch because of excessive anastomosis tension and
the attendant higher risk of ﬁstula.
The age at which preventive surgical treatment is indi-
cated is based on the following objective data: age of onset
of polyps, age of transformation of polyps in other family
members, the patient’s signs and symptoms, risk of cancer
based on colonoscopy and periodic biopsies, and the spe-
ciﬁc type of mutation identiﬁed in that patient/family. Surgery
with preservation of the rectum should be accepted by the
12About 15 cm should be retained to preserve the reservoir func-
tion of the rectal remnant: this permits fecal continence, but
patients may have some degree of urgency and increased
o j). 2
r
colectomy and ileorectal anastomosis for familial12  j coloproctol (ri
frequency of bowel movements (on average ﬁve times a
day).12,13
Both surgical techniques studied were associated with
recurrent or underlying polyps; however, with TC, which pre-
serves a segment of the rectum, polyps appeared earlier and
were more  numerous and dense. In those who have under-
gone TPC, the risk of metachronous cancer in the ileal pouch
is small; however, adenomas reportedly occur more  frequently
as time passes.14,15 The risk of CRC is higher around the anus,
where polyps may occur in the remnant mucosal ring between
the dentate line and the straight line section of the double sta-
pling technique. However, compared with TC, recurrent polyps
occur less frequently and are in a more  favorable location for
resection, which may reduce the incidence of cancer.
In addition to the high frequency of polyps in classic poly-
posis, various other factors are responsible for the higher
incidence of metachronous lesions in this condition, includ-
ing varying extent of colonic resection, varying indications
for surgery according to age, the locus of the mutation, the
diverse histology of polyps and follow-up time; the incidence
of polyps reaches over 40% by 20 years after surgery.8–11,16,17
One of our cases was diagnosed with metachronous rectal can-
cer (T1N0M0) after 5 months of total colectomy with ileorectal
anastomosis, undergoing salvage treatment by complete proc-
tectomy and ileal pouch anal anastomosis. The failure of
preoperative colonoscopy to detect synchronous dysplastic
lesions is one of the causes of early diagnosis after short-term
follow-up. We  therefore recommend detailed preoperative
endoscopic evaluation of rectal polyps by experienced special-
ists.
When the anal canal is ﬁlled with polyps, care must be
taken during mucosal resection so as not to injure the inter-
nal anal sphincter. Intestinal transit can be reconstructed by
performing a manual ileoanal anastomosis transanally, as
proposed by Parks and Percy.18 However, many  studies have
found that this technique produces worse functional results
than the double stapling technique, the latter preserves good
sensory function in the anal transition zone, which is impor-
tant in maintaining an acceptable frequency of evacuation and
anal continence.9,12,16,17,19
Introduction of new types of stapler that facilitate resection
and reconstruction and decrease the duration of surgery have
recently been associated with a steep learning curve and
improvement in surgical techniques, such that restorative
proctocolectomy and ileal pouch anal anastomosis have been
increasingly accepted for treatment of classical polyposis. Sev-
eral series have shown that most individuals are satisﬁed with
the resultant quality of life and preservation of fecal conti-
nence; however, other functional outcomes vary.13,20,21 Some
women avoid sexual activity for fear of dyspareunia and fecal
incontinence, the latter being reported in 3–22% of cases. In
addition, fashioning of an ileal pouch may reduce fertility; this
can also occur in individuals who  have undergone same type
of surgery for other reasons.13,22–24 Depending on the surgical
technique, men  may experience erectile dysfunction (0–1.5%)
and premature ejaculation (3–4%) because of denervation of
the pelvic plexus.20,21,23,24
12Aziz et al. performed a meta-analysis of 12 published
studies comprising 1002 patients in all; six of these studies
reported signiﬁcantly fewer reoperations within 30 days in the 0 1 5;3 5(1):8–13
TC group than in the TPC group (OR 2.11, range of 95% CI: 1.21,
3.70). There were no signiﬁcant differences between these two
procedures in incidence of intestinal obstruction (reported in
10 studies), postoperative hemorrhage (three studies), intra-
abdominal sepsis (eight studies), anastomotic leakage (ﬁve
studies) or wound infection (six studies). However, accurate
comparison of morbidities in these studies was hindered by
a lack of uniformity in reporting types of complications and
a diversity of ages and comorbidities. Despite these factors,
both published reports and our objective data generally indi-
cate that TPC is associated with more  frequent complications
and poorer functional outcomes than TC, which is of partic-
ular concern in patients at low risk of metachronous rectal
cancer. Thus, the choice between these two techniques should
be made on an individual basis.
Conclusions
Every individual with FAP has a high risk of developing CRC
and the best form of preventive treatment available is surgery.
Surgical morbidity is not negligible in either of the two surgical
techniques studied; therefore, treatment should be provided
by specialized reference centers that offer genetic counseling
to family members.
In order to provide a better quality of life to individuals with
FAP, TC with ileorectal anastomosis is commonly offered; this
technique is simple and traditionally associated with lower
rates of postoperative complications and better functional
outcomes. However, because it is associated with a signiﬁ-
cantly higher probability of metachronous rectal cancer, it has
become a less attractive technique in patients with the clas-
sical or diffuse form of FAP. The option of TPC confers a lower
risk of CRC.
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